Webinar

How Will COVID-19 Change Telehealth and Alternative Payment Models?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Screenshot of an interview with Nicolas Girard, MD, PhD
4 experts in this video
4 experts in this video
Related Content
COA President Debra Patt, MD, PhD, MBA
September 15th 2025

With Remote Patient Monitoring, Picking Tools Is Easier Than Change Management

Mary Caffrey
Managed Care Cast thumbnail
September 15th 2025

Navigating the Alzheimer Disease Blood Test Revolution

Maggie L. Shaw Howard Fillit, MD Anthony "Nino" Sireci, MD, MSc
Lori A. Leslie, MD | Image: John A. Theurer Cancer Center
September 15th 2025

Phase 2 Study Shows Feasibility of Axi-Cel Delivery in Outpatient Setting

Mary Caffrey
Managed Care Cast Logo
September 15th 2025

AI in Health Care: Balancing Governance, Innovation, and Trust

Maggie L. Shaw Reuben Daniel
Most Favored Nation | Image Credit: © AliFuat-stock.adobe.com
September 15th 2025

Unpacking the Complexity of the Most Favored Nation Mandate

Maggie L. Shaw
The iRR6 may help identify those who are unlikely to derive long-term benefit from ruxolitinib and could be considered for alternative therapies. | Image credit: mdaros - stock.adobe.com
September 15th 2025

Refined iRR6 Model Improves Risk Stratification in Intermediate-1 Myelofibrosis

Kimberly Rath, PharmD

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo